The Olink platform delivers exceptional sensitivity and specificity for protein biomarker measurement. Olink Explore HT is the company’s latest solution for high-throughput proteomics, allowing scientists to accurately measure over 5,300 proteins using only 2 microliters of sample.
Discoveryās Proteome Center provides the most current technologies in mass spectrometry, plasma proteomics, and the entire spectrum of Olink solutions, including Olink Explore HT, Explore 3072, Target, Focus, and Flexāeach designed to suit a variety of scientific objectives. The Center possesses the scientific expertise to maximize the capability of these state-of-the-art technologies to measure thousands of proteins from only microliters of complex samples, including plasma and serum, in a single experiment.
āWe are extremely excited to see the entire portfolio of Olink proteomics solutions being adopted by Discovery Life Sciences, a global leader in proteomic applications,ā said Mike Irwin, Olink VP of Sales and Marketing. āAs part of a worldwide network of service providers and with their biospecimen specialty and state-of-the-art Olink proteomics solutions implementation, Discovery is well-positioned to contribute to a safer and healthier world.ā
āDiscovery continues to stay ahead of the proteomics revolution,ā said Glenn Bilawsky, Discovery CEO. āBy integrating Olink Explore HT with our access to the worldās largest biospecimen inventory and the advanced robotic automation of our Proteome Center, we significantly enhance the quality, speed, and efficiency of protein biomarker analyses. We can provide target specimens for analysis and derive more data from smaller samples in less time than our competitors. Our continued investment in innovative technologies like Olink Explore HT further empowers us to fulfill our mission of helping our clients advance new therapies and diagnostics to patients and their caregivers.”
Discovery Life Sciences is the company of Biospecimen and Biomarker Specialists. We combine a comprehensive commercial biospecimen inventory and procurement network with outstanding multi-omic biomarker service laboratories. Our offerings include genomic, tissue biomarker, proteomic, and cell-based services, accelerating the development of new therapies supported by biomarker and companion diagnostic programs for cancer, infectious disease, and other rare and complex conditions.
